Late-Breaking Data Demonstrate Improved Progression-Free Survival in Patients with Metastatic Colorectal Cancer After Treatment with Boston Scientific TheraSphere™ Y-90 Glass Microspheres
VB Profiles,
EPOCH trial represents the first positive phase 3 study for selective internal radiation therapy MARLBOROUGH, Mass., Sept.